Dongyue He
-
- Immune cells in cancer 4
- Phagocytosis and Immune Regulation 2
- interferon and immune responses 1
-
- Extracellular vesicles in disease 5
-
- Nanoparticle-Based Drug Delivery 2
-
- Nanoplatforms for cancer theranostics 5
-
- Cardiovascular Disease and Adiposity 1
-
- Tissue Engineering and Regenerative Medicine 1
- Co-authors
- Chunping LiuZhijin FanLongmei LiShihui ZhangJiaxin ChiYichao WangHuiqi ChenLei Wang
In The Last Decade
Dongyue He
14 papers receiving 330 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 76
- Immunology 84
- Molecular Biology 184
- Biomaterials 33
- Biomedical Engineering 73
Countries citing papers authored by Dongyue He
This map shows the geographic impact of Dongyue He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyue He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyue He more than expected).
Fields of papers citing papers by Dongyue He
This network shows the impact of papers produced by Dongyue He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyue He. The network helps show where Dongyue He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dongyue He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 22 | |
| 6 | 2022 | 33 | |
| 7 | 2022 | 19 | |
| 8 | 2022 | 104 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 61 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 29 | |
| 14 | 2016 | 2 |
About Dongyue He
Dongyue He is a scholar working on Immunology, Pharmaceutical Science and Urology, having authored 14 papers that have together received 335 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (5 papers), Nanoplatforms for cancer theranostics (5 papers), Immune cells in cancer (4 papers), Nanoparticle-Based Drug Delivery (2 papers), Phagocytosis and Immune Regulation (2 papers), interferon and immune responses (1 paper), Cardiovascular Disease and Adiposity (1 paper) and Tissue Engineering and Regenerative Medicine (1 paper). The work is most often cited by research in Cancer Research (76 citations), Immunology (84 citations) and Molecular Biology (184 citations). Dongyue He has collaborated with scholars based in China, Macao and Ethiopia. Frequent co-authors include Chunping Liu, Zhijin Fan, Longmei Li, Shihui Zhang, Jiaxin Chi, Yichao Wang, Huiqi Chen, Lei Wang, Yixiao Wu and Yuhui Liao. Their work appears in journals such as Advanced Functional Materials, Journal of Controlled Release and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.